Leviathan as a partial cure? Opportunities and pitfalls of using the state-owned apparatus to respond to the COVID-19 crisis

dc.contributor.authorSERGIO GIOVANETTI LAZZARINI
dc.contributor.authorMusacchio, Aldo
dc.coverage.cidadeRio de Janeiropt_BR
dc.coverage.paisBrasilpt_BR
dc.creatorMusacchio, Aldo
dc.date.accessioned2022-10-13T21:57:26Z
dc.date.available2022-10-13T21:57:26Z
dc.date.issued2020
dc.description.otherWhile some argue that market forces are imperative to stimulate the increased supply of critical products and services to address the COVID-19 crisis, others contend that dealing with the pandemic requires coordination and rapid adjustments in supply that may be constrained by a host of factors. Although discussions have centered on policies to promote financial liquidity, we examine whether the state apparatus—not only state-owned enterprises but also development agencies and investment funds—can innovate and adjust production processes to improve infrastructure and capabilities to prevent and treat the disease. Potential actions include public-private effort addressing both discovery and coordination problems—such as a collaborative effort to develop prevention and treatment technologies, as well as state capital to stimulate retooling and expansion of strategic infrastructure. The state apparatus can also help access remote and critical areas with relatively lower private returns. In contrast, support to industries must be implemented with caution, especially for sectors whose demand may suffer permanently due to lifestyle changes. Exit strategies must be carefully crafted to avoid the risk of perpetuating unjustified and ineffective state support, establishing milestones and termination clauses based on clear performance indicators. We argue that, although using the state apparatus as a countermeasure entails a set of risks, not using it may increase the risk of extending the crisis and end with an overloaded state sector (e.g., due to massive bailouts), challenging the implementation of subsequent adjustments.pt_BR
dc.format.extentp. 561-577pt_BR
dc.format.mediumDigitalpt_BR
dc.identifier.doihttp://dx.doi.org/10.1590/0034-761220200120xpt_BR
dc.identifier.issue4pt_BR
dc.identifier.urihttps://repositorio.insper.edu.br/handle/11224/4279
dc.identifier.volume54pt_BR
dc.language.isoInglêspt_BR
dc.publisherNão informadopt_BR
dc.relation.ispartofBrazilian Journal of Public Administrationpt_BR
dc.rights.licenseO INSPER E ESTE REPOSITÓRIO NÃO DETÊM OS DIREITOS DE USO E REPRODUÇÃO DOS CONTEÚDOS AQUI REGISTRADOS. É RESPONSABILIDADE DOS USUÁRIOS INDIVIDUAIS VERIFICAR OS USOS PERMITIDOS NA FONTE ORIGINAL, RESPEITANDO-SE OS DIREITOS DE AUTOR OU EDITORpt_BR
dc.subject.keywordsCOVID-19pt_BR
dc.subject.keywordsstate-owned enterprisespt_BR
dc.subject.keywordsdevelopment bankspt_BR
dc.subject.keywordsstate capitalismpt_BR
dc.titleLeviathan as a partial cure? Opportunities and pitfalls of using the state-owned apparatus to respond to the COVID-19 crisispt_BR
dc.title.alternativeO Leviatã como uma cura parcial? Oportunidades e armadilhas no uso do aparato estatal para responder à crise da COVID-19pt_BR
dc.title.alternative¿Leviatán como una cura parcial? Oportunidades y dificultades al usar el aparato estatal para responder a la crisis de COVID-19pt_BR
dc.typejournal article
dspace.entity.typePublication
local.subject.cnpqCiências Sociais Aplicadaspt_BR
local.typeArtigo Científicopt_BR
relation.isAuthorOfPublication4ee022f9-7466-405d-ae1a-6b1e33f611e8
relation.isAuthorOfPublication.latestForDiscovery4ee022f9-7466-405d-ae1a-6b1e33f611e8

Arquivos

Pacote original

Agora exibindo 1 - 2 de 2
N/D
Nome:
R_Artigo_2020_Leviathan as a partial cure_TC.pdf
Tamanho:
262.25 KB
Formato:
Adobe Portable Document Format
Descrição:
R_Artigo_2020_Leviathan as a partial cure_TC
Imagem de Miniatura
Nome:
Acesso_Primeira Pagina_Leviathan as a partial cure Opportunities and pitfalls of using the state-owned apparatus to respond to the COVID-19 crisis.pdf
Tamanho:
103.04 KB
Formato:
Adobe Portable Document Format

Licença do pacote

Agora exibindo 1 - 1 de 1
N/D
Nome:
license.txt
Tamanho:
282 B
Formato:
Item-specific license agreed upon to submission
Descrição: